David Donnell

1.2k total citations
29 papers, 894 citations indexed

About

David Donnell is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, David Donnell has authored 29 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in David Donnell's work include Inhalation and Respiratory Drug Delivery (12 papers), Asthma and respiratory diseases (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). David Donnell is often cited by papers focused on Inhalation and Respiratory Drug Delivery (12 papers), Asthma and respiratory diseases (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). David Donnell collaborates with scholars based in United Kingdom, United States and Netherlands. David Donnell's co-authors include William W. Busse, Gene Colice, Jennifer A. Vanden Burgt, Shari A. Brazinsky, C.P. van Schayck, Kraig W. Jacobson, W. Stricker, Stanley J. Szefler, Richard J. Martin and Lester I. Harrison and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

David Donnell

29 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Donnell United Kingdom 17 629 602 73 66 65 29 894
Ann Allen United Kingdom 17 396 0.6× 377 0.6× 79 1.1× 39 0.6× 61 0.9× 45 873
Ruediger Nave Japan 15 572 0.9× 604 1.0× 42 0.6× 20 0.3× 38 0.6× 20 806
R. Nave Germany 14 443 0.7× 449 0.7× 30 0.4× 25 0.4× 65 1.0× 41 722
P. J. G. Cornelissen Netherlands 14 1.1k 1.8× 907 1.5× 88 1.2× 14 0.2× 26 0.4× 24 1.3k
Alan Hamilton Canada 25 1.8k 2.9× 1.3k 2.1× 154 2.1× 24 0.4× 21 0.3× 74 2.2k
Rhys Jones United Kingdom 16 225 0.4× 149 0.2× 128 1.8× 26 0.4× 59 0.9× 34 744
Nathan J. Brown Australia 21 990 1.6× 840 1.4× 237 3.2× 6 0.1× 39 0.6× 79 1.6k
Sally Meah United Kingdom 11 328 0.5× 390 0.6× 108 1.5× 12 0.2× 9 0.1× 16 717
Robert L. Kunka United States 14 99 0.2× 131 0.2× 114 1.6× 12 0.2× 48 0.7× 20 468
Zöe Borrill United Kingdom 15 752 1.2× 528 0.9× 52 0.7× 6 0.1× 7 0.1× 20 1.0k

Countries citing papers authored by David Donnell

Since Specialization
Citations

This map shows the geographic impact of David Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Donnell more than expected).

Fields of papers citing papers by David Donnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Donnell. The network helps show where David Donnell may publish in the future.

Co-authorship network of co-authors of David Donnell

This figure shows the co-authorship network connecting the top 25 collaborators of David Donnell. A scholar is included among the top collaborators of David Donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Donnell. David Donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chhabra, A. Bobby, Anthony Bentley, David Donnell, et al.. (2006). OA4 A HEALTH-ECONOMIC EVALUATION OF RHBMP-2 IN SPINE FUSION SURGERY IN GERMANY AND UK. Value in Health. 9(6). A201–A201. 1 indexed citations
2.
Schayck, C.P. van & David Donnell. (2004). The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 2): clinical experience in children. International Journal of Clinical Practice. 58(8). 786–794. 21 indexed citations
3.
Schayck, C.P. van & David Donnell. (2004). The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (Part 1): an update of clinical experience in adults. International Journal of Clinical Practice. 58(7). 678–688. 24 indexed citations
4.
Donnell, David, et al.. (2002). Dental findings in 4‐, 14‐, and 25‐to 35‐year‐old Hong Kong residents with mental and physical disabilities. Special Care in Dentistry. 22(6). 231–234. 22 indexed citations
5.
Ahrens, Richard C., et al.. (2001). Asthma Stability After Oral Prednisone. American Journal of Respiratory and Critical Care Medicine. 164(7). 1138–1145. 12 indexed citations
6.
Bodsworth, Neil, Mark Bloch, Mark Bower, David Donnell, & Richard C. Yocum. (2001). Phase III Vehicle-Controlled, Multi-Centered Study of Topical Alitretinoin Gel 0.1% in Cutaneous AIDS-Related Kaposi??s Sarcoma. American Journal of Clinical Dermatology. 2(2). 77–87. 64 indexed citations
7.
Donnell, David. (2001). Optimizing Drug Delivery to the Lung: Design of a CFC-Free Corticosteroid Metered-Dose Aerosol System. Drug Development and Industrial Pharmacy. 27(2). 111–118. 2 indexed citations
8.
Burgt, Jennifer A. Vanden, William W. Busse, Richard J. Martin, Stanley J. Szefler, & David Donnell. (2000). Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. Journal of Allergy and Clinical Immunology. 106(6). 1209–1226. 114 indexed citations
9.
Busse, William W., Shari A. Brazinsky, Kraig W. Jacobson, et al.. (1999). Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant☆☆☆★. Journal of Allergy and Clinical Immunology. 104(6). 1215–1222. 211 indexed citations
10.
Thompson, P., R.J. Davies, W. F. Young, Andrew B. Grossman, & David Donnell. (1998). Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol. Respiratory Medicine. 92. 33–39. 50 indexed citations
11.
Dahl, Ronald, et al.. (1997). EQUIVALENCE OF ASTHMA CONTROL WITH NEW CFC‐FREE FORMULATION HFA‐134a BECLOMETHASONE DIPROPIONATE AND CFC‐BECLOMETHASONE DIPROPIONATE. International Journal of Clinical Practice. 51(1). 11–15. 27 indexed citations
12.
Dockhorn, Robert J., et al.. (1995). Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma. Journal of Allergy and Clinical Immunology. 96(1). 50–56. 39 indexed citations
13.
Donnell, David, S. A. Ward, Lester I. Harrison, et al.. (1995). Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler. European Journal of Clinical Pharmacology. 48(6). 473–7. 36 indexed citations
14.
Voss, Hans‐Peter, et al.. (1994). A functional beta-2 adrenoceptor-mediated chronotropic response in isolated guinea pig heart tissue: selectivity of the potent beta-2 adrenoceptor agonist TA 2005.. Journal of Pharmacology and Experimental Therapeutics. 271(1). 386–389. 18 indexed citations
15.
Glaser, Robert, et al.. (1993). Solution- and Solid-State Structures of N-Desmethylnefopam Hydrochloride, a Metabolite of the Analgesic Drug. Journal of Pharmaceutical Sciences. 82(3). 276–281. 6 indexed citations
16.
17.
Glaser, Robert, David Donnell, & Knut Maartmann-Moe. (1992). Solid-State Structure of Orphenadrine Hydrochloride and Conformational Comparisons with Diphenhydramine Hydrochloride and nefopam hydrochloride. Journal of Pharmaceutical Sciences. 81(9). 858–862. 8 indexed citations
18.
Voss, Hans‐Peter, David Donnell, & Aalt Bast. (1992). Atypical molecular pharmacology of a new long-acting β2-adrenoceptor agonist, TA 2005. European Journal of Pharmacology Molecular Pharmacology. 227(4). 403–409. 35 indexed citations
19.
Hunskaar, Steinar & David Donnell. (1991). Clinical and Pharmacological Review of the Efficacy of Orphenadrine and Its Combination with Paracetamol in Painful Conditions. Journal of International Medical Research. 19(2). 71–87. 33 indexed citations
20.
Glaser, Robert & David Donnell. (1989). Stereoisomer Differentiation for the Analgesic Drug Nefopam Hydrochloride Using Modeling Studies of Serotonin Uptake Area. Journal of Pharmaceutical Sciences. 78(2). 87–90. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann Allen Breakdown of academic impact, for papers by Ruediger Nave Breakdown of academic impact, for papers by R. Nave Breakdown of academic impact, for papers by P. J. G. Cornelissen Breakdown of academic impact, for papers by Alan Hamilton Breakdown of academic impact, for papers by Rhys Jones Breakdown of academic impact, for papers by Nathan J. Brown Breakdown of academic impact, for papers by Sally Meah Breakdown of academic impact, for papers by Robert L. Kunka Breakdown of academic impact, for papers by Zöe Borrill
Rankless by CCL
2026